Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W57
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,123
Award facts
- Contract value 100% obligated
- $70,123.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $70,123.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL, with an ultimate completion date of January 22, 2026. The award, announced on January 21, 2026, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Cosentyx, a biologic medication used for autoimmune inflammatory conditions, represents part of the company's extensive portfolio fulfilling federal medical supply requirements for military treatment facilities and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1W57?
SPE2DR26F1W57 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1W57 worth?
The government has obligated $70,123 on SPE2DR26F1W57.
Is contract SPE2DR26F1W57 an order under another contract?
Yes. SPE2DR26F1W57 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W57 competed?
The extent of competition for SPE2DR26F1W57 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award